Seeking Alpha

Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 35 years executive experience including Abbott and JNJ and has been involved three successful start-ups. Before starting Raygent and other companies he was also a... More
My company:
Raygent Capital
My blog:
Raygent.com,Rayno Life Science
  • Rayno Life Science Stocks Rally: Green Screen... IBB UP 2.5% 0 comments
    Mar 18, 2014 3:29 PM | about stocks: ACHN, EXAS

    Rayno Biopharmaceutical and Diagnostic Stocks In BIG Rally

    Biggest movers in Biopharma-Large Caps Still Rule Near All Time Highs

    ALXN, AMGN, BIIB, GILD, REGN

    Mid and Small Cap movers: AMRI, CBST, IMGN, SGEN

    Achillion Pharmaceuticals (ACHN $3.54) our only loser is looking better. We added more at $3.40.

    Diagnostic Stocks Pick Up Steam Up Over 2%

    EXAS up 8% anticipating colorectal screening test approval.

    CPHD, GHDX, NSPH, QDEL, QGEN

    Investment posture: maintain 15% cash, stay with Rayno Portfolio stocks, avoid high fliers and small cap speculative stocks. Using ETFs as a marker the sector is at the low end of a rising channel up 17% YTD.

    Chart foriShares Nasdaq Biotechnology (NASDAQ:<a href='http://seekingalpha.com/symbol/ibb' title='iShares Nasdaq Biotechnology ETF'>IBB</a>)

    Disclosure: I am long ACHN.

    Additional disclosure: I am long Fidelity Select Biotechnology Fund (FBIOX) and short selective mid cap stocks as a hedge.

    Stocks: ACHN, EXAS
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.